Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).
Notes:
Data are from the most recent national surveys available in each country (see Table GPS-4 in the 2006 statistical bulletin).
Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may to a small extent account for disparities between countries.
Czech Republic: 2004; 18-34 y. n=1414
Denmark: 2000; 16-34 y. n=4141
Germany: 2003; 18-34 y. n=3775
Estonia: 2003; 15-34 y. n=646
Greece: 2004; 15-34 y. n=2620
Spain: 2003; 15-34 y. n=5357
France: 2002; 15-34 y. n=724
Italy: 2003; 15-34 y. n=5231
Cyprus: 2003; 15-34 y. n=580
Latvia: 2003; 15-34 y. n=
Lithuania: 2004; 15-34 y. n=1814
Hungary: 2003; 18-34 y. n=2319
Netherlands: 2000/01; 15-34 y. n=6687
Austria: 2004; 15-34 y. n=1754
Poland: 2002; 16-34 y. n=
Portugal: 2001; 15-34 y. n=6406
Slovakia: 2004; 15-34 y. n=578
Finland: 2004; 15-34 y. n=1031
UK (E&W): 2004/05; 16-34 y. n=9913
Bulgaria: 2005; 18-34 y. n=433
Norway: 2004; 15-34 y. n=1238
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Sources:
Reitox national reports (2005), taken from population surveys, reports or scientific articles.
See also Table GPS-0.